Yes, the release on the 20th was their initial reaction to looking at results of the efficacy trial, which I believe they were blind to until the trial concluded. People who attended the Wall St. Conference knew the trial would end on or about the 20th of March.

I believe that many people thought their would be substantial data then, but frankly while they were thrilled with what they were seeing, it takes time to put the data in a meaningful form, and then it should be submitted for peer review somewhere before it's made available to investors.

I frankly don't know where such data should be presented, but I believe it will be in time. Many of the technical conferences I've seen in the past required Abstracts be submitted several months before the conference. It could be a few months before such a presentation, but I would hope that some additional information would be included with the Annual Report due by the end of this week unless they apply for a 15 day delay.

I've been an investor in the company for roughly 5 months. I don't know if they routinely do a webcast when presenting Annual, or Quarterly reports. I would hope that we have a webcast and I would expect an announcement shortly on what's happening WRT an annual report.

Gary